Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - TOTAL CURRENT LIABILITIES
Total Current Liabilities FATE - Fate Therapeutics, Inc.
39.1 M
LAST VALUE
-30.65%
2 YEAR CAGR
7.47%
5 YEAR CAGR
23.86%
10 YEAR CAGR